Sep 28, 2021
Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
CONCLUSIONS: The set of radiomic signatures was found to have limited ability to discriminate nivolumab responders from non-responders. The use of novel texture features (two-point correlation measure, two-point cluster measure, and minimum spanning tree measure) did not improve performance.